Concepedia

Publication | Open Access

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia

DOIFull Paper Access

246

Citations

17

References

2015

Year

Kenneth L. Subotnik, Laurie R. Casaus, Joseph Ventura, John Luo, Gerhard Hellemann, Denise Gretchen‐Doorly, Stephen R. Marder, Keith H. Nuechterlein
JAMA Psychiatry

Abstract

clinicaltrials.gov Identifier: NCT00333177.

References

YearCitations

Page 1